Search results

  1. E

    News from Germany

    For what it's worth Karl Lauterbach seems to be the first and only health minister to ever take ME/CFS and Long Covid seriously and speak publicly about all problems. I hope some change is still possible under his reign, especially since what comes next doesn't look good at all, but knowing...
  2. E

    News from Germany

    It doesn't seem so. The 15 Million are 5 Million per year for medical research. What Lauterbach wants, is 60 Million extra for healthcare research, for which 40 Million have already been allocated by him. However, as we know healthcare research is extremely useless if you don't do biomedical...
  3. E

    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19, 2023, Cakir

    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19 Abstract Clinical and histopathological evidence suggest that the male reproductive system may be negatively impacted in patients with coronavirus disease (COVID-19). The objective of this study is to...
  4. E

    Professor Akiko Iwasaki and the Yale School of Medicine research on Long Covid and post infection syndromes

    Unfortunately, I couldn't find any information on funding. When I googled them I at least found out that they are currently recruiting for one position, probably not the worst of signs...
  5. E

    Professor Akiko Iwasaki and the Yale School of Medicine research on Long Covid and post infection syndromes

    Merged thread Post-Acute Infection Syndromes Will Be the Focus of New YSM Center https://medicine.yale.edu/news-article/post-acute-infection-syndromes-will-be-the-focus-of-new-ysm-center/ Researchers will investigate Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and...
  6. E

    SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency, 2023, Li et al

    SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency Abstract Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for prolonged SARS-CoV-2 infection, but the immune defects that predispose to persistent COVID-19 remain incompletely...
  7. E

    Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic.., 2023, Seibert

    Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors Abstract Background The Long-COVID syndrome constitutes a plethora of persisting symptoms with neurological disorders being the most...
  8. E

    German Government announces new funding guidelines for ME/CFS

    Yes, however the 40 million by Karl Lauterbach can only be used for health care research. So this budget is relatively useless if you don't spend money on biomedical research.
  9. E

    German Government announces new funding guidelines for ME/CFS

    The first reports by politicians are that the allocated funding by the German Government is 10 Million for Long-Covid research and 5 Million for ME/CFS research for the year 2024. Sounds extremely dissapointing.
  10. E

    The Observer/Guardian article: Does the microbiome hold the key to chronic fatigue? About patient led 'research' group Remission Biome.

    The donor that donated another 250K is Vitalik Buterin. He has also donated very large sums to PolyBio and the Patient-Led Research Collaborative. His key principles seem to be that everything is open source, is openly shared and a focus seems to be that progress should be quicker than going...
  11. E

    Polybio Fall 2023 Symposium

    Polybio Fall 2023 Symposium "Join us online Friday Oct. 20 for updates on PolyBio supported projects & collaborations including those spearheaded by the #LongCovid Research Consortium. " Register on Zoom:https://us02web.zoom.us/webinar/register/WN__cnUbsaISb-D0AtXQ9yGbQ#/registration Speakers...
  12. E

    Professor Akiko Iwasaki and the Yale School of Medicine research on Long Covid and post infection syndromes

    Merged thread Akiko Iwasaki speaks on BBC- Science in Action https://www.bbc.co.uk/sounds/play/w3ct4scs (around 10:00 I believe). She talks about the recent Keystone Symposium and ongoing findings. A focus seems to be microclots, viral persistence, EBV and some of Nath's findings.
  13. E

    Preprint Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review, 2023, Agarwal et al

    Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review Abstract COVID-19, caused by the SARS-CoV-2 virus, initially identified as a respiratory illness, has increasingly been linked to a broader range of organ complications. This...
  14. E

    ‘Hardcore science’ or ‘just a sticker’ – do anti-anxiety patches actually work?

    Of course it's just a sticker. Only the “quantum biosignal AI processing discs” really work. Can't believe they missed out on both "quantum" and "AI", what amateurs.
  15. E

    What can I do to treat covid-19 infection?

    I'd like to add, for me it was always good to swab both nose and mouth, only doing one sometimes gave a negative. In my case mouth seemed to be of particular importance. Paxlovid still has a great impact on preventing severe infections, at least that is my understanding. From what I can tell...
  16. E

    What can I do to treat covid-19 infection?

    I think Rapid tests are still worth it. There are concerns about their accuracy with all the variants that have come and gone, but whenever I had Covid a rapid test detected it extremely reliably, of course a PCR test is far more accurate. I don't think it would be too early for a Rapid test...
  17. E

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases, 2023,

    I haven't looked at the exact cohorts yet. It would be interesting to know whether any patients were taking immunosuppressants to treat RA during their acute infection. Very broadly speaking I would think that those that are immunocompromised would be more likely to develop a persistent virus...
  18. E

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases, 2023,

    An article: https://medicalxpress.com/news/2023-09-clues-patients-rheumatic-diseases-potential.html. Different studies that follow a similar line of thought and that even identified OC43 as well: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awad155/7158783?login=false...
  19. E

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases, 2023,

    Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases Editor’s summary It is not clear why some individuals develop postacute sequelae of COVID-19 (PASC) while others do not. Here, Herman et al. used systems serology...
  20. E

    German Government announces new funding guidelines for ME/CFS

    Yes. It's certainly a big problem that even if there was money I wouldn't know who to give it to in many countries. However, making funding country dependent is also very important to actually get new researchers into the field, something that has been a massive problem in ME/CFS research and...
Back
Top Bottom